A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease

NCT02912936 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease
Primary Progressive Non-fluent Aphasia
Frontotemporal Dementia (FTD)

Interventions

DIETARY_SUPPLEMENT: Ketogenic medium chain triglyceride drink (MCT drink)
DIETARY_SUPPLEMENT: Placebo

Sponsor

University of British Columbia

Collaborators

[object Object]